CMV-Specific T-Cell Immune Responses in Older vs. Younger Kidney Transplant Recipients
Background. Compared with younger patients on similar immunosuppression regimens, older solid-organ transplant recipients experience increased rates of infection and death, but decreased rates of rejection. The mechanism behind these differences has yet to be defined, but may be related to ÒinflammagingÓ driven by CMV infection. The objective of this study was to evaluate older vs. younger solid-organ transplant recipients for CMV-specific T-cell immune responses.
Methods. Peripheral blood mononuclear cells were isolated from 20 older ( 3 age 60) and 25 matched younger (ages 30-59) kidney transplant recipients at 3 months after transplantation. Eight recipients were high risk by CMV serology (D+/R−) and 37 were intermediate risk (D−/R+). Overlapping CMV peptide pools were used for stimulation. Intracellular staining to determine cytokine stimulation was performed by multiparameter flow cytometry. Statistical analysis was performed using Jmp Pro 11 software.
Results. There was no association between patient age and CMV risk status (P = 0.728). There was no difference between older and younger kidney transplant recipients in release of IFNγ, TNFα, or IL-2 from CD4+ or CD8+ T cells in response to CMV antigen stimulation. However, Older recipients had similar frequencies of CD8+ naive cells but decreased frequency of CD8+ terminally differentiated effector memory CD45RA+ (TEMRA) T cells releasing both IFNg and TNFa (P = 0.037) (figure) . Interestingly, development of CMV viremia was associated with a weaker CMVspecific immune response: Patients who had a history of CMV viremia had a decreased frequency of CD8+ TEMRA cells releasing both IFNγ and TNFα (P = 0.041).
Conclusion.
Older kidney transplant recipients demonstrated a decreased frequency of CMV-specific polyfunctional CD8+ TEMRA T cells. This impaired memory T-cell response to CMV suggests a possible mechanism for the increased vulnerability of older recipients to CMV infection or reactivation, which may in turn worsen age-related immune dysfunction. Furthermore, patients with subsequent CMV viremia had a decreased frequency of CMV-specific polyfunctional CD8+ TEMRA T cells. This finding may explain patient vulnerability to CMV viremia despite modern protocols for antiviral prophylaxis. Background. Immune activation complicates HIV despite antiretroviral therapy (ART). Indoleamine 2,3 dioxygenase (IDO) catabolizes tryptophan (T) to kynurenine (K), regulating immune activity. IDO activity increases in HIV patients and non-HIV patients with age. This study examines the relationship of IDO activity, bacterial translocation, and ageing in HIV patients on ART. We hypothesize that increased IDO activity caused by bacterial translocation is a factor in inflammation during aging.
Disclosures
Methods. Samples and data from virologically suppressed HIV patients on ART in specific age strata were obtained from the Centers for AIDS Research Network of Integrated Clinical Systems. Samples and data from age and sex-matched healthy controls were obtained from the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. The ratio of K to T (K/T) and neopterin were used as indicators of inflammation; 16S ribosomal DNA (16S rDNA) and lipopolysaccharide (LPS) served as markers of bacterial translocation. Log transformation, chi-square tests, t-tests with Satterthwaite adjustment for continuous data, ANOVA, and ANCOVA homogeneity of slopes model were used.
Results. Samples and data from 205 HIV patients and 99 matched controls were analyzed. HIV patients had higher K/T values across all ages. Younger HIV patients had greater K/T values than older healthy controls. Age, sex or race was not associated with differences in K/T. Current CD4 count or CD4 nadir had no association with K/T ratio. For HIV patients, there was an inverse relationship between LPS detection and K/T. For controls, there was no association between LPS and K/T. There was no association between PCR detection of 16S rDNA and K/T ratio in HIV patients or controls. Both groups had positive association between K/T ratio and neopterin.
Conclusion. HIV patients have elevated K/T, even at younger ages, despite virologic control. The main hypothesis that K/T increases with advancing age was not supported in this cohort. Also, unlike other published literature, CD4 nadir, LPS, and 16S rDNA did not correlate with K/T ratio. This study suggests there may be an alternative driver of immune inflammation in well-controlled HIV patients other than bacterial translocation. 
